Open Access Editorial
Charis Liapi,1,2
, Apostolos Zarros1,*
1College of Pharmacy, University of Babylon, Hillah, Iraq
2Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
*Corresponding author: Apostolos Zarros, College of Pharmacy, University of Babylon, Hillah, Iraq; Tel.: +44-(0)7391071851
E-mail: dr.apostolos.zarros@uobabylon.edu.iq
Download PDF
Published: 5 May 2024; https://doi.org/10.61873/VBNU2182
Abstract
The proceedings of the 1st International Babylon Conference on Clinical and Experimental Pharmacological Research (taking place at the College of Pharmacy of the University of Babylon, in Hillah, Iraq; May 4-5, 2024) are hereby hosted by the Review of Clinical Pharmacology and Pharmacokinetics – International Edition; a journal that has provided a significant service to the international pharmacological community since 1987. These proceedings include a total of 50 papers (including this editorial) and provide a representative overview of the conference’s rich scientific programme. The latter has served two objectives: (i) to facilitate the mapping of the Iraqi pharmacological research and priorities, and (ii) to enable the establishment of international collaborations in the field. In that respect, the proceedings host the inspiring messages of several conference keynote speakers from abroad, and feature a variety of clinical and experimental studies that well relate to the priorities currently set by the Iraqi pharmacological community.
Keywords: Iraq, pharmacological research, ethnopharmacology, antibiotic resistance, nanopharmacology
Please cite as:
Liapi C., Zarros A. The 1st International Babylon Conference on Clinical and Experimental Pharmacological Research: mapping the Iraqi pharmacological research activity and priorities. Rev. Clin. Pharmacol. Pharmacokinet. Int. Ed. 38 (Sup2): 1-2 (2024). https://doi.org/10.61873/VBNU2182